Treatment algorithm developed with Dr. McCullough et al. & Dr. Zelenko, I was 2nd author; note how we have added nasal-oral hygiene wash in the 2nd row up top 6 x day; lost a few patients to acute

by Paul Alexander

COVID-19 respiratory illness & key factor each time has been heart failure combined to a late start early therapeutics; early start key even if hospitalized & get multidrug home treatment, survives!



Dr. McCullough highlights a good paper by Palazzuoli et al. with New Risk Stratification and Advanced Protocols Allowing Home Treatment.

‘The interplay between COVID-19 infection and HF remains complex because infection may deteriorate a stable HF condition and concurrent events may promote vascular and respiratory complications leading to clinical deterioration. Additionally, some drugs tested in the acute phase of infection may facilitate arrhythmic events and fluid retention, leading to HF. High-risk patients with multiple CV diseases and an early HF stage deserve a careful approach, possibly avoiding the deleterious effects of some agents currently employed during hospitalization. In certain categories without respiratory complications, home care based on nutraceutical agents and common anti-inflammatory drugs is probably preferable in order to reduce hospitalization and guarantee tailored HF management.’

Courageous Discourse™ with Dr. Peter McCullough & John Leake
Ambulatory Acute COVID-19 Care Extends to Heart Failure Patients
By Peter A. McCullough, MD, MPH As a cardiologist, I have lost a few patients to acute COVID-19 respiratory illness and a key factor each time has been heart failure combined with a late start on early therapeutics. The hospital is too late to start treatment for acute COVID-19 in patients with left ventricular dysfunction. Palazzuoli et al have publis…
Read more